Potentiation of the radiation effect with genistein in cervical cancer cells

Gynecologic Oncology

Volumn 99, Issue 1, 2005, Pages 199-205

  Yashar, Catheryn M ^a   Spanos, William J ^a   Taylor, Douglas D ^a   Gercel Taylor, Cicek ^a  

^a University of Louisville School of Medicine   (United States)

Author keywords

Cervical cancer; Genistein; Radiosensitivity

Indexed keywords

GENE PRODUCT; GENISTEIN;

ARTICLE; CANCER CELL; CANCER STAGING; CELL SURVIVAL; COLONY FORMATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORRELATION ANALYSIS; HUMAN; HUMAN CELL; PRIORITY JOURNAL; RADIATION RESPONSE; RADIOSENSITIZATION; STATISTICAL SIGNIFICANCE; UTERINE CERVIX CANCER; WESTERN BLOTTING;

ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CELL CYCLE; CELL GROWTH PROCESSES; CELL LINE, TUMOR; COMBINED MODALITY THERAPY; CYTOCHROMES C; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; GENISTEIN; HUMANS; ISOFLAVONES; NEOPLASM PROTEINS; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-AKT; PROTO-ONCOGENE PROTEINS C-BCL-2; RADIATION-SENSITIZING AGENTS; UTERINE CERVICAL NEOPLASMS;

EID: 25144436299     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ygyno.2005.07.002     Document Type: Article

References (30)

1. P.A. Wingo, T. Tong, and S. Bolden Cancer statistics CA Cancer J. Clin. 45 1995 8
2. S.A. Leibel, and T.L. Phillips Oncology: carcinoma of the uterine cervix Textbook of Radiation 1998 WB Saunders Company 799
3. C.S. Whitney, W. Sause, and B.N. Bundy Randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stages IIB-IVA carcinoma of the cervix with negative para-aortic lymph nodes: a gynecologic oncology group and southwest oncology group study J. Clin. Oncol. 16 1999 1339 1348
4. M. Morris, P.J. Eifel, and J. Lu Pelvic radiation with concurrent chemotherapy versus pelvic and paraaortic radiation for high-risk cervical cancer: a randomized therapy oncology group clinical trial N. Engl. J. Med. 340 1999 1137 1143
5. P.G. Rose, B.N. Bundy, and F.B. Stehman Concurrent cisplatin-based chemoradiation improves progression-free and overall survival in advanced cervical cancer: results of a randomized gynecologic oncology group study N. Engl. J. Med. 340 1999 1144 1153
6. H.M. Keys, B.N. Bundy, and F.B. Stehman A comparison of weekly cisplatin during radiation therapy versus irradiation alone, each followed by adjuvant hysterectomy in bulky stage 1B cervical carcinoma: a randomized trial of the gynecologic oncology group N. Engl. J. Med. 340 1999 1154 1161
7. W.A. Peters III, P.Y. Liu, and R.J. Barrett Cisplatin and 5-fluorouracil plus radiation therapy are superior to radiation therapy as adjunctive in high-risk early-stage carcinoma of the cervix after radical hysterectomy and pelvic lymphadenectomy: report of a phase III intergroup study Soc. Gynecol. Oncol. 72 1999 443 [Abstract]
8. G.G. Hillman, J.D. Forman, and O. Kucuk Genistein potentiates the radiation effect on prostate carcinoma cells Clin. Cancer Res. 7 2001 382 390
9. T. Akimoto, T. Nonaka, and H. Ishikawa Genistein, a tyrosine kinase inhibitor, enhanced radiosensitivity in human esophageal cancer cell lines in vitro: possible involvement of inhibition of survival signal transduction pathways Int. J. Radiat. Oncol. Biol. Phys. 50 1 2001 195 201
10. S.Y. Wang, K.W. Yang, Y.T. Hsu, C.L. Chang, and Y.C. Yang The differential inhibitory effects of genistein on the growth of cervical cancer cells in vitro Neoplasma 48 2001 227 233
11. E.J. Hawryleciwz, H.H. Huang, and W.H. Blair Dietary soybean isolate and methionine supplementation affect mammary tumor progression in rats J. Nutr. 121 1991 1693 1698
12. M. Masai, K. Abe, S. Akimoto, R. Yatani, and J. Shimazaki Argyrophilic nucleolar organizer regions in benign hyperplastic and cancerous human prostates Prostate 20 1992 1 13
13. L. Chiusa, D. Galliano, A. Formiconi, O. Di-Primio, and A. Pich High and low risk prostate carcinoma determined by histologic grade and proliferative activity Cancer 79 1997 1956 1963
14. T. Shirai, K. Imaida, S. Iwasaki, T. Mori, M. Tada, and N. Ito Sequential observation of rat prostate lesion development induced by 3,2′-dimethyl- 4-aminobiphenyl and testosterone Jpn. J. Cancer Res. 84 1993 20 25
15. T. Tanaka, T. Takeuchi, A. Nishikawa, T. Takami, and H. Mori Nucleolar organizer regions in hepatocarcinogenesis induced by N-2-fluorenylacetamide in rats: comparison with bromodeoxyuridine immunohistochemistry Jpn. J. Cancer Res. 80 1989 1047 1051
16. C.A. Lamartiniere, J.B. Moore, N.M. Brown, R. Thompson, M.J. Hardin, and S. Barnes Genistein suppresses mammary cancer in rats Carcinogenesis 16 1995 2833 2840
17. J. Markovits, C. Linassier, and P. Fosse Inhibitory effects of the tyrosine kinase inhibitor genistein on mammalian DNA topoisomerase II Cancer Research 49 1989 5111 5117
18. T. Fotsis, M. Pepper, H. Adlercreutz, T. Hase, R. Montesano, and L. Schweiggerer Genistein, a dietary ingested isoflavonoid, inhibits cell proliferation and in vitro angiogenesis J. Nutr. 125 1995 790s 797s
19. K.D.R. Setchell Phytoestrogens: the biochemistry, physiology, and implications for human health of soy isoflavones Am. J. Clin. Nutr. 68 6 Suppl. 1998 1333S 1346S
20. WAF1 Clin. Cancer Res. 7 2001 1782 1789
21. K. Dampier, L.M. Hudson, M.M. Manson, R.A. Walker, and A. Gescher Differences between human breast cell lines in susceptibility towards growth inhibition by genistein Br. J. Cancer 85 2001 618 624
22. C. Gercel-Taylor, A.K. Feitelson, and D.D. Taylor Inhibitory effect of genistein and daidzein on ovarian cancer cell growth Anticancer Research 24 2004 795 800
23. 2-M arrest and apoptosis J. Cell. Biochem. 69 1998 44 54
24. Y. Li, S. Upadhyay, M. Bhuiyan, and F.H. Sarkar Induction of apoptosis in breast cancer cells MDA-MB-231 by genistein Oncogene 18 1999 3166 3172
25. K.A. West, S. Castillo, and P.A. Dennis Activation of the P13k/Akt pathway and chemotherapeutic resistance Drug Resist. Updates 5 2002 234 248
26. A.E. Clark, K. West, S. Streicher, and P.A. Dennis Constitutive and inducible Akt activity promotes resistance to chemotherapy, trastuzumab, and tamoxifen in breast cancer cells Mol. Cancer Ther. 1 2002 707 717
27. F.M. Yakes, W. Chinratanalab, C.A. Ritter, W. King, S. Seelig, and C.L. Arteaga Herceptin-induced inhibition of phosphytidylinositol-3 kinase and Akt is required for antibody-mediated effects on p27, cyclin D1, and anti-tumor action Cancer Res. 62 2002 4132 4141
28. L.H. Wei, M.L. Kuo, and C.A. Chen The anti-apoptotic role of interleukin-6 in human cervical cancer is mediated by up-regulation of Mcl-1 through a PI3-K/Akt pathway Oncogene 20 2001 5799 5809
29. F.H. Sarkar, and W. Li The role of isoflavones in cancer chemoprevention Front. Biosci. 9 2004 2714 2727
30. M.G. Busby, A.R. Jeffcoat, and M.A. Bloedon Clinical characteristics and pharmacokinetics of purified soy isoflavones: single-dose administration to healthy men Am. J. Clin. Nutr. 75 2002 126 136